Viral infection is governed by dynamic interactions that structural snapshots and ensemble measurements cannot fully resolve. High-speed atomic force microscopy (HS-AFM) enables direct, real-time visualization of these events at nanometer spatial and sub-second temporal resolution without fluorescent labeling or chemical fixation. This presentation highlights our application of HS-AFM to SARS-CoV-2 spike dynamics, receptor recognition, and antibody engagement. Imaging reveals spike stalk and receptor-binding domain flexibility, environmentally induced conformational changes, and interactions with angiotensin-converting enzyme 2 (ACE2) and small extracellular vesicles (sEVs). Engineered spike-displaying sEVs provide a noninfectious platform for observing antibody interactions with membrane-associated wild-type and Delta spike proteins, offering mechanistic insights complementary to conventional neutralization assays. Extending this approach beyond virology, antibody-based profiling of CD63 and CD81 distinguishes sEV subpopulations, while PD-L1 antibody docking on breast cancer-derived sEVs, including those from patient-derived tumor cell cultures, reveals heterogeneous binding frequency and dwell time. These findings demonstrate how molecular accessibility and interaction dynamics add information beyond protein abundance, connecting virological research with broader biomedical applications. Future integration with standardized sample preparation and automated analysis could enable functional liquid biopsy approaches for biomarker discovery, disease monitoring, and treatment-response assessment. With improved throughput and clinical validation, HS-AFM could help bridge nanoscale disease mechanisms with the development of diagnostic and therapeutic strategies.